Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
about
The developing story of Sprouty and cancer.Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by EpigeneticsSprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinomaThe genomics and genetics of endometrial cancer.Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines.Aberrant expression of hSef and Sprouty4 in endometrial adenocarcinoma.Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis.Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.Endometrial carcinoma: molecular alterations involved in tumor development and progression.Molecular pathology of endometrial carcinoma.DNA methylation and apoptosis resistance in cancer cellsCarcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.Endometrial Carcinoma: Specific Targeted Pathways.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer.FGFR2 alterations in endometrial carcinoma
P2860
Q33962853-0ADC349F-F319-43B0-BB9A-8608D0711BC2Q35882785-FE3DA6AD-C81B-419B-B55E-BF40BFC6F311Q36043347-6F29400D-CFF4-4E46-AD47-D87AA05EB69AQ36151896-CA21D691-63B2-4275-A879-D478F07C3B9DQ36454937-65823296-1EA1-45C1-B426-612F91518B84Q36502806-2FD95004-4481-4C29-8B41-164F801C15E0Q36686648-2D0290BA-61DD-4FF7-A6BA-25E158DBDEC9Q37475506-1927D992-BC15-4ACF-995E-560BBCE1305EQ37697198-9730C07E-119C-409E-B01D-DFA62918E635Q37994980-D2D2398C-8B27-4FA3-B0EA-ED43E9C5D558Q38067440-A724D738-4E56-4CD1-B5DE-9A6A98A8D203Q38202821-3213B0AF-E539-4E20-999B-31FB67C50BB3Q38240724-9DB8D66F-3227-4130-87D0-7EE244B7104FQ38630962-82056ED4-F4DC-42B1-ABD1-61AEEB9895CCQ39026766-831213ED-122D-4376-ACC0-1DBFB7479A3CQ39282288-276060A1-2DB2-49F4-A48E-D562C364D641Q41513194-C4335185-652D-44A4-9E68-C58D8A2D9EA5Q59123115-ABEB9F58-9839-4FD6-8F48-07E59AA24F11
P2860
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@en
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@nl
type
label
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@en
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@nl
prefLabel
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@en
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@nl
P2093
P50
P1433
P1476
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
@en
P2093
Andree Yeramian
Judit Pallares
Melisa Fernandez
Monica Domingo
Sonia Gatius
Xavier Dolcet
Xavier Matias-Guiu
P304
P356
10.1016/J.HUMPATH.2010.08.001
P407
P577
2010-11-26T00:00:00Z